Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Atherosclerosis

1,2,3,4-tetrahydroquinoline has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Demarest, KT; Kuo, GH; Pelton, PD; Rano, TA; Sieber-McMaster, E; Yang, M	1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Atherosclerosis

Article	Year
Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform. Bioorganic & medicinal chemistry letters, 2009, May-01, Volume: 19, Issue:9 Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Dogs; Drug Design; Haplorhini; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Quinolines; Risk Factors	2009

Article

Year

Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform.

Bioorganic & medicinal chemistry letters, 2009, May-01, Volume: 19, Issue:9

Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Dogs; Drug Design; Haplorhini; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Quinolines; Risk Factors

2009